[Acting point of placental coagulation inhibitor]. 1985

Y Shidara

In the previous paper, the methods of purification of placental coagulation inhibitor (PCI) were reported. This paper deals with the acting point of the PCI on the coagulation process. Prothrombin time, activated partial thromboplastin time, Russell's viper venom time, and recalcification time were all prolonged by PCI. Neither thrombin time nor Echis carinatus venom time was affected by PCI. Factors XII, XI, X, IX, VIII, VII and V were not inactivated by the incubation with PCI. PCI had no activities of fibrinolysis, antifibrinolysis and protein Ca. In the intrinsic pathways, activity of phospholipid seemed to be inhibited by PCI. The tissue thromboplastin activity was completely inactivated by incubation with PCI.

UI MeSH Term Description Entries
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

Y Shidara
June 1951, Bollettino della Societa italiana di biologia sperimentale,
Y Shidara
January 1961, Archiv fur Gynakologie,
Y Shidara
July 1954, Magyar noorvosok lapja,
Y Shidara
June 1951, Bollettino della Societa italiana di biologia sperimentale,
Y Shidara
June 2001, Clinics in laboratory medicine,
Y Shidara
January 2018, International journal of clinical and experimental pathology,
Y Shidara
December 2008, Nature chemical biology,
Y Shidara
September 1964, Zentralblatt fur Gynakologie,
Y Shidara
May 1976, Thrombosis research,
Y Shidara
March 2016, Topics in companion animal medicine,
Copied contents to your clipboard!